Skip to content

Stylized cells, blue

Category: Cell & Gene Therapy

From Academia to Commercialization: Addressing Challenges in Next-Gen Cell Therapies

Part 13 of our Bridging the Gap Series (Summary of the webinar session held in December 2024) Groundbreaking advancements in cell and gene therapies offer unprecedented hope for patients battling cancers, autoimmune diseases, and genetic disorders. Yet, transforming academic breakthroughs into therapies ready for patients is a complex and challenging journey.  Issues such as scalable manufacturing processes, […]

View Blog

Securing Critical Quality Attributes (CQA) of CGT Products with Strong In-House Cryo Cold Chain Management

Part 1 of our Cryo Cold Chain Management for CGT Series With a projected rate of 10-20 product approvals per year, the global cell and gene therapy (CGT) industry is rapidly evolving. The clinical pipeline delivers a promise to the patient population with unmet medical needs ranging from oncology to autoimmune diseases and rare genetic conditions. In […]

View Blog

Unlocking the Curative Power of Gene Therapies for All Patients

Part 12 of our Bridging the Gap Series (Summary of the webinar session held in November 2024) Pictured in photo: Sickle cell warrior Jimi Olaghere climbed Mt. Kilimanjaro after receiving advanced gene therapy. The incredible potential of gene therapies like chimeric antigen receptor T-cell therapy (CAR-T) and clustered regularly interspaced short palindromic repeats (CRISPR) to cure genetic diseases […]

View Blog

Celebrating One Year of Bridging the Gap: A Transformative Webinar Series for the Cell and Gene Therapy Community

Recap of 1 Year of our Bridging the Gap Series In November 2024, Azenta Life Sciences celebrated the one-year anniversary of its “Bridging the Gap” webinar series, an insightful resource in cell and gene therapy (CGT) education, co-sponsored by the Emily Whitehead Foundation. Over the past year, this series has become a resource for industry experts and […]

View Blog

The Future of Cell and Gene Therapy: Breaking Barriers to Access and Innovation

Part 11 of our Bridging the Gap Series (Summary of the webinar session held in October 2024) In the rapidly advancing world of cell and gene therapy, we are witnessing groundbreaking innovations that have the potential to cure once-incurable diseases like cancer and sickle cell. Yet, as these transformative therapies emerge, a troubling reality persists: access to […]

View Blog

Addressing Equity of Access to Advanced Therapies

Part 10 of our Bridging the Gap Series (Summary of the webinar session held in September 2024) Access to life-saving cell and gene therapies is one of the most critical challenges facing healthcare today. While these therapies offer remarkable hope for patients battling life-threatening conditions like cancer and rare genetic diseases, the reality is that only a […]

View Blog

Breaking Bottlenecks: Enhancing Autologous Cell Therapy Manufacturing

Part 9 of our Bridging the Gap Series (Summary of the webinar session held in August 2024) In the evolving landscape of cell and gene therapy, the manufacturing process is a crucial factor in ensuring that innovative treatments, such as CAR T-cell therapies, reach patients effectively. Autologous cell therapies, which involve modifying a patient’s own cells, present […]

View Blog

Six Steps for a Successful Transition to Automated Cryogenic Storage

Imagine a scenario where a prominent life sciences company safeguards 573,000 biological samples collected two decades ago during a groundbreaking study. Today, these samples rest in a tucked-away basement of a modest laboratory, nestled among numerous cryogenic freezers within a section of the building inaccessible to anyone involved in the original research. The samples intermingle […]

View Blog

Attacking Solid Tumors: TIL Revolution and Next Generation Advanced Therapies

Part 8 of our Bridging the Gap Series (Summary of the webinar session held in July 2024) Imagine harnessing your body’s own immune cells to fight and destroy cancer—a reality that Tumor-Infiltrating Lymphocytes (TIL) therapy is making possible. TIL therapy was the key topic of our July “Bridging the Gap” webinar with guest speaker Raj Puri, M.D., […]

View Blog

Bridging the Gap: Enhancing Global Access to Advanced Therapies

Part 7 of our Bridging the Gap Series (Summary of the webinar session held in June 2024) What if you could transform the life of a child with leukemia by simply modifying their own cells? This is the promise of CAR T-cell therapy, a groundbreaking treatment that has already revolutionized cancer care. Yet, as Siddhartha Mukherjee, M.D., […]

View Blog